|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000014771 |
|
Date of registration:
|
01/09/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Influence of febuxostat and Topiroxostat on renal function
|
|
Scientific title:
|
Influence of febuxostat and Topiroxostat on renal function - Influence of febuxostat and Topiroxostat on renal function |
|
Date of first enrolment:
|
2014/09/01 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Complete: follow-up complete |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017179 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel Randomized
|
|
Phase:
|
Not selected
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Akira Sezai |
|
Address:
|
30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan
Japan |
|
Telephone:
|
03-3972-8111 |
|
Email:
|
asezai.med@gmail.com |
|
Affiliation:
|
Nihon University School of Medicine Department of Cardiovascular Surgery |
|
|
Name:
|
Akira Sezai |
|
Address:
|
30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan
Japan |
|
Telephone:
|
03-3972-8111 |
|
Email:
|
asezai.med@gmail.com |
|
Affiliation:
|
Nihon University School of Medicine Department of Cardiovascular Surgery |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Patients from whom informed consent was not obtained
Age minimum:
20years-old
Age maximum:
90years-old
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
hyperuricemia
|
|
Intervention(s)
|
Febuxostat group
Topiroxostat group
|
|
Primary Outcome(s)
|
|
1) Serum uric acid 2) Urinary Albumin
|
|
Secondary Outcome(s)
|
|
1) serum Cr 2) eGFR 3) cystatin C 4) Oxidized LDL 5) T-cho, TG, LDL,HDL 6)PWV 7)BNP, EF, LVM 8) side effects
|
|
Source(s) of Monetary Support
|
|
self funding
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
31/12/2015 |
|
URL:
|
|
|
|